Hyperterm interperitoneal kemoterapi ved den primære operation for gastrointestinal cancer

Translated title of the contribution: Hyperthermic intraperitoneal chemotherapy at the primary gastrointestinal cancer operation

Thea Helene Degett, Hans-Christian Pommergaard, Ismail Gögenur

Abstract

Up to 20% of the patients who undergo radical surgery for colorectal cancer experience recurrence. Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery have shown to be effective treatment of peritoneal carcinomatosis. HIPEC administered at the primary operation in high-risk patients may also be effective in preventing peritoneal carcinomatosis and improve survival in patients with advanced gastrointestinal cancer.

Translated title of the contributionHyperthermic intraperitoneal chemotherapy at the primary gastrointestinal cancer operation
Original languageDanish
JournalUgeskrift for Laeger
Volume179
Issue number12
Pages (from-to)V06160454
ISSN0041-5782
Publication statusPublished - 20 Mar 2017

Keywords

  • English Abstract
  • Journal Article

Fingerprint

Dive into the research topics of 'Hyperthermic intraperitoneal chemotherapy at the primary gastrointestinal cancer operation'. Together they form a unique fingerprint.

Cite this